|
WO2021055595A1
|
|
Systems and methods for detection and prevention of emergence of agitation
|
|
WO2021016112A2
|
|
Non-sedating dexmedetomidine treatment regimens
|
|
WO2020123496A1
|
|
Novel approach for treatment of cancer using immunomodulation
|
|
TW202038942A
|
|
Combination therapies for treating disease using an innate immunity modifier and an ox40 agonist
|
|
US2020000717A1
|
|
Film formulations containing dexmedetomidine and methods of producing them
|
|
EP3813828A1
|
|
Methods for treating agitation using dexmedetomidine hydrochloride
|
|
US2020317784A1
|
|
Methods and compositions for treating cancer by modifying multiple arms of the immune system
|
|
EP3565560A1
|
|
Predictive and diagnostic methods for prostate cancer
|
|
CA3045043A1
|
|
Use of sublingual dexmedetomidine for the treatment of agitation
|
|
CA2991628A1
|
|
A novel approach for treatment of cancer using immunomodulation
|
